Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Plano

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Molecules (Basel, Switzerland)|August 3, 2017
Novel Methylselenoesters as Antiproliferative AgentsNuria Díaz-Argelich, Ignacio Encío, Daniel Plano, et al.
Current Medicinal Chemistry|February 26, 2013
Bisacylimidoselenocarbamates cause G2/M arrest associated with the modulation of CDK1 and Chk2 in human breast cancer MCF-7 cellsIranzu Lamberto, Daniel Plano, Esther Moreno, et al.
European Journal of Medicinal Chemistry|November 23, 2011
Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: synthesis and study of their potential cytotoxic activity in vitroEsther Moreno, Daniel Plano, Iranzu Lamberto, et al.
Archiv Der Pharmazie|December 4, 2025
New Se-Compounds With Antileishmanial, Antitumor, and Carbonic Anhydrase Inhibitory PropertiesCristina Morán-Serradilla, Daniel Plano, Andrea Angelli, et al.
European Journal of Medicinal Chemistry|December 1, 2010
Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamatesElena Ibáñez, Daniel Plano, María Font, et al.
Journal of Molecular Graphics & Modelling|June 30, 2015
Molecular descriptors calculation as a tool in the analysis of the antileishmanial activity achieved by two series of diselenide derivatives. An insight into its potential action mechanismMaría Font, Ylenia Baquedano, Daniel Plano, et al.
European Journal of Medicinal Chemistry|September 27, 2025
Synthesis and characterization of novel phenyl carboxamide-selenium analogs: Identification of a potent DHODH inhibitor as a potential anticancer agentCristina Morán-Serradilla, Carmen Sanmartín, Asif Raza, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Norbornene and Related Structures as Scaffolds in the Search for New Cancer TreatmentsGorka Calvo-Martín, Daniel Plano, Nuria Martínez-Sáez, et al.
Metabolites|September 23, 2022
Seleno-Metabolites and Their Precursors: A New Dawn for Several Illnesses?Cristina Morán-Serradilla, Eduardo Angulo-Elizari, Andreina Henriquez-Figuereo, et al.
Journal of Medicinal Chemistry|January 12, 2016
Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer AgentsDaniel Plano, Deepkamal N Karelia, Manoj K Pandey, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Molecules (Basel, Switzerland)|August 3, 2017
Novel Methylselenoesters as Antiproliferative AgentsNuria Díaz-Argelich, Ignacio Encío, Daniel Plano, et al.
Current Medicinal Chemistry|February 26, 2013
Bisacylimidoselenocarbamates cause G2/M arrest associated with the modulation of CDK1 and Chk2 in human breast cancer MCF-7 cellsIranzu Lamberto, Daniel Plano, Esther Moreno, et al.
European Journal of Medicinal Chemistry|November 23, 2011
Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: synthesis and study of their potential cytotoxic activity in vitroEsther Moreno, Daniel Plano, Iranzu Lamberto, et al.
Archiv Der Pharmazie|December 4, 2025
New Se-Compounds With Antileishmanial, Antitumor, and Carbonic Anhydrase Inhibitory PropertiesCristina Morán-Serradilla, Daniel Plano, Andrea Angelli, et al.
European Journal of Medicinal Chemistry|December 1, 2010
Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamatesElena Ibáñez, Daniel Plano, María Font, et al.
Journal of Molecular Graphics & Modelling|June 30, 2015
Molecular descriptors calculation as a tool in the analysis of the antileishmanial activity achieved by two series of diselenide derivatives. An insight into its potential action mechanismMaría Font, Ylenia Baquedano, Daniel Plano, et al.
European Journal of Medicinal Chemistry|September 27, 2025
Synthesis and characterization of novel phenyl carboxamide-selenium analogs: Identification of a potent DHODH inhibitor as a potential anticancer agentCristina Morán-Serradilla, Carmen Sanmartín, Asif Raza, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Norbornene and Related Structures as Scaffolds in the Search for New Cancer TreatmentsGorka Calvo-Martín, Daniel Plano, Nuria Martínez-Sáez, et al.
Metabolites|September 23, 2022
Seleno-Metabolites and Their Precursors: A New Dawn for Several Illnesses?Cristina Morán-Serradilla, Eduardo Angulo-Elizari, Andreina Henriquez-Figuereo, et al.
Journal of Medicinal Chemistry|January 12, 2016
Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer AgentsDaniel Plano, Deepkamal N Karelia, Manoj K Pandey, et al.
Pageof 9